Cell-specific Delivery of a Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor to Proximal Tubular Cells for the Treatment of Renal Fibrosis
Jai Prakash(Radboud University Nijmegen), Robbert J. Kok(Utrecht University), M. Lacombe(Université du Québec à Rimouski), Annemiek M. van Loenen-Weemaes(University of Groningen), Klaas Poelstra(University of Groningen), Frits Moolenaar(University of Groningen), Martin H. de Borst(University Medical Center Groningen), Frank Opdam(Alltech (United States)), Dirk K. F. Meijer(University of Groningen), Harry van Goor(University Medical Center Groningen)
Cited by 46
Related Papers
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
|Drug Resistance Updates|2005|461
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|Advanced Drug Delivery Reviews|2013|396
Criteria for definition of a complex abdominal wall hernia
|Hernia|2013|340
Diverse origins of the myofibroblast—implications for kidney fibrosis
|Nature Reviews Nephrology|2015|305